Coronary Artery Disease Cad clinical trials

Explore recruiting coronary artery disease cad clinical trials.

Recruiting coronary artery disease cad studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Coronary Artery Disease Cad trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to see how RO7763505 works and how safe it is when given to healthy people and people with stable heart disease

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 3, Multicenter, Open Label Study to Confirm the Diagnostic Potential of Intravenously Administered 15O- H2O to Identify Coronary Artery Disease During Pharmacological Stress and Resting Conditions Using PET Imaging

Denmark, Sweden, Germany, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE)

Finland, France, Spain

Therapeutic use (Phase IV) EU CTIS Study details

A multiarm, randomized, open label Clinical study comparing AntiatheroSClerotic efficacy of selected Antidiabetic agents in patients with coronary artery disease and preDiabetES. A randomised clinical trial (CASCADES)

Poland

Therapeutic use (Phase IV) EU CTIS Study details

Coronary Artery Disease Cad trials by city

Coronary Artery Disease Cad clinical trials

Recruiting coronary artery disease cad studies right now

Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography

Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction

Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention

Effectiveness of a Resilience-Based Rehabilitation Program for Patients With Coronary Heart Disease

Community Exercise Treating Effect on Cardiopulmonary Disease Patients

Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia

A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease

Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment

Ketamine-lidocaine Versus Ketamine-fentanyl for Induction of Anesthesia in Patients With Left Ventricular Systolic Dysfunction Undergoing Elective Coronary Artery Bypass

Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation

Optimal Stent Deployment Strategy of Contemporary Stents

CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2)